Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure

Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure: A Randomized Controlled Pilot Study: ASSIST-HF SIRIO

The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.

Inclusion Criteria:

• Age ≥ 18 years
• Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge

Exclusion Criteria

• Known prior history of HF
• Severe comorbidities that could affect protocol adherence, in the opinion of the investigator
• Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease
• Dementia or other cognitive impairment
• Currently involved in another interventional clinical trial